- Home
- VIVK vs CASI Comparison
VIVK vs CASI Comparison
Compare VIVK & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVK
- CASI
- Stock Information
- Founded
- VIVK 2006
- CASI 1991
- Country
- VIVK United States
- CASI China
- Employees
- VIVK N/A
- CASI N/A
- Industry
- VIVK Oilfield Services/Equipment
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- VIVK Energy
- CASI Health Care
- Exchange
- VIVK Nasdaq
- CASI Nasdaq
- Market Cap
- VIVK 38.4M
- CASI 35.8M
- IPO Year
- VIVK N/A
- CASI 1996
- Fundamental
- Price
- VIVK $0.68
- CASI $2.39
- Analyst Decision
- VIVK
- CASI Strong Buy
- Analyst Count
- VIVK 0
- CASI 1
- Target Price
- VIVK N/A
- CASI $4.00
- AVG Volume (30 Days)
- VIVK 183.5K
- CASI 411.7K
- Earning Date
- VIVK 08-19-2025
- CASI 08-29-2025
- Dividend Yield
- VIVK N/A
- CASI N/A
- EPS Growth
- VIVK N/A
- CASI N/A
- EPS
- VIVK N/A
- CASI N/A
- Revenue
- VIVK $124,048,464.00
- CASI $31,564,000.00
- Revenue This Year
- VIVK N/A
- CASI N/A
- Revenue Next Year
- VIVK N/A
- CASI N/A
- P/E Ratio
- VIVK N/A
- CASI N/A
- Revenue Growth
- VIVK 98.83
- CASI 36.64
- 52 Week Low
- VIVK $0.53
- CASI $1.09
- 52 Week High
- VIVK $1.89
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- VIVK 39.10
- CASI 60.66
- Support Level
- VIVK $0.67
- CASI $2.18
- Resistance Level
- VIVK $0.88
- CASI $2.50
- Average True Range (ATR)
- VIVK 0.07
- CASI 0.24
- MACD
- VIVK -0.01
- CASI -0.02
- Stochastic Oscillator
- VIVK 4.99
- CASI 68.75
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.